Literature DB >> 22330011

Good practice in reviewing and publishing studies on herbal medicine, with special emphasis on traditional Chinese medicine and Chinese materia medica.

Kelvin Chan1, Debbie Shaw, Monique S J Simmonds, Christine J Leon, Qihe Xu, Aiping Lu, Ian Sutherland, Svetlana Ignatova, You-Ping Zhu, Rob Verpoorte, Elizabeth M Williamson, Pierre Duez.   

Abstract

ETHNOPHARMACOLOGICAL RELEVANCE: Studies on traditional Chinese medicine (TCM), like those of other systems of traditional medicine (TM), are very variable in their quality, content and focus, resulting in issues around their acceptability to the global scientific community. In an attempt to address these issues, an European Union funded FP7 consortium, composed of both Chinese and European scientists and named "Good practice in traditional Chinese medicine" (GP-TCM), has devised a series of guidelines and technical notes to facilitate good practice in collecting, assessing and publishing TCM literature as well as highlighting the scope of information that should be in future publications on TMs. This paper summarises these guidelines, together with what has been learned through GP-TCM collaborations, focusing on some common problems and proposing solutions. The recommendations also provide a template for the evaluation of other types of traditional medicine such as Ayurveda, Kampo and Unani.
MATERIALS AND METHODS: GP-TCM provided a means by which experts in different areas relating to TCM were able to collaborate in forming a literature review good practice panel which operated through e-mail exchanges, teleconferences and focused discussions at annual meetings. The panel involved coordinators and representatives of each GP-TCM work package (WP) with the latter managing the testing and refining of such guidelines within the context of their respective WPs and providing feedback.
RESULTS: A Good Practice Handbook for Scientific Publications on TCM was drafted during the three years of the consortium, showing the value of such networks. A "deliverable - central questions - labour division" model had been established to guide the literature evaluation studies of each WP. The model investigated various scoring systems and their ability to provide consistent and reliable semi-quantitative assessments of the literature, notably in respect of the botanical ingredients involved and the scientific quality of the work described. This resulted in the compilation of (i) a robust scoring system and (ii) a set of minimum standards for publishing in the herbal medicines field, based on an analysis of the main problems identified in published TCM literature.
CONCLUSION: Good quality, peer-reviewed literature is crucial in maintaining the integrity and the reputation of the herbal scientific community and promoting good research in TCM. These guidelines provide a clear starting point for this important endeavour. They also provide a platform for adaptation, as appropriate, to other systems of traditional medicine.
Copyright © 2012 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22330011     DOI: 10.1016/j.jep.2012.01.038

Source DB:  PubMed          Journal:  J Ethnopharmacol        ISSN: 0378-8741            Impact factor:   4.360


  33 in total

Review 1.  A systematic review and meta-analysis on the use of traditional Chinese medicine compound kushen injection for bone cancer pain.

Authors:  Bao Yanju; Liping Yang; Baojin Hua; Wei Hou; Zhan Shi; Weidong Li; Conghuang Li; Cihui Chen; Rui Liu; Yinggang Qin; Wenliang Lv
Journal:  Support Care Cancer       Date:  2013-11-26       Impact factor: 3.603

Review 2.  An overview on adverse drug reactions to traditional Chinese medicines.

Authors:  Kelvin Chan; Hongwei Zhang; Zhi-Xiu Lin
Journal:  Br J Clin Pharmacol       Date:  2015-05-19       Impact factor: 4.335

Review 3.  Traditional Chinese Medicine (TCM) and Herbal Hepatotoxicity: RUCAM and the Role of Novel Diagnostic Biomarkers Such as MicroRNAs.

Authors:  Rolf Teschke; Dominique Larrey; Dieter Melchart; Gaby Danan
Journal:  Medicines (Basel)       Date:  2016-07-19

Review 4.  Food allergy prevalence: new possibilities for therapy and prevention.

Authors:  Yan Ma
Journal:  Wien Med Wochenschr       Date:  2012-11-28

5.  Traditional Chinese Medicine Use among Patients with Psoriasis in Taiwan: A Nationwide Population-Based Study.

Authors:  Shu-Wen Weng; Bor-Chyuan Chen; Yu-Chiao Wang; Chun-Kai Liu; Mao-Feng Sun; Ching-Mao Chang; Jaung-Geng Lin; Hung-Rong Yen
Journal:  Evid Based Complement Alternat Med       Date:  2016-10-16       Impact factor: 2.629

Review 6.  Heliotropium indicum L.: From Farm to a Source of Bioactive Compounds with Therapeutic Activity.

Authors:  Chandan Sarkar; Milon Mondal; Bilkis Khanom; Md Monir Hossain; Md Solayman Hossain; Antoni Sureda; Muhammad Torequl Islam; Miquel Martorell; Manoj Kumar; Javad Sharifi-Rad; Ahmed Al-Harrasi; Ahmed Al-Rawahi
Journal:  Evid Based Complement Alternat Med       Date:  2021-06-01       Impact factor: 2.629

Review 7.  The quest for modernisation of traditional Chinese medicine.

Authors:  Qihe Xu; Rudolf Bauer; Bruce M Hendry; Tai-Ping Fan; Zhongzhen Zhao; Pierre Duez; Monique S J Simmonds; Claudia M Witt; Aiping Lu; Nicola Robinson; De-an Guo; Peter J Hylands
Journal:  BMC Complement Altern Med       Date:  2013-06-13       Impact factor: 3.659

8.  East meets West: current issues relevant to integrating Chinese medicine.

Authors:  Emily Yen Wong; Barak Gaster; Sum Ping Lee
Journal:  Chin Med       Date:  2012-09-03       Impact factor: 5.455

Review 9.  Chinese herbal medicine for aspirin resistance: a systematic review of randomized controlled trials.

Authors:  Ai-Ju Liu; Hui-Qin Li; Ji-Huang Li; Yuan-Yuan Wang; Dong Chen; Yan Wang; Guo-Qing Zheng
Journal:  Evid Based Complement Alternat Med       Date:  2014-02-20       Impact factor: 2.629

Review 10.  Approaches in fostering quality parameters for medicinal botanicals in the Indian context.

Authors:  Pooja D Gupta; Poonam G Daswani; Tannaz J Birdi
Journal:  Indian J Pharmacol       Date:  2014 Jul-Aug       Impact factor: 1.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.